Even though the pharma market increased 19% last year, according to Cegedim, and at the same time exports of pharmaceutical products have also seen an upward trend, and the pharmaceutical industry represents, in the opinion of Petru Crăciun, the general manager of Cegedim, "one of Romania"s main creditors", the operations of companies in the sector evolved differently. Thus, some of the companies went from losing money to being profitable, others, and quite a few of them, went from making money to losing it. Some saw their profits shrink, whereas quite a few of them posted higher profits. However, according to information published on the website of the Ministry of Public Finance , they all have outstanding debt.
* "Sanofi-Aventis" - a fourfold increase in profit
"Sanofi-Aventis" has increased its profit four times, in 2010 compared to 2009, from 2.43 million lei to almost 10.5 million lei. Also, the turnover increased, to 898 million lei, from 562 million lei. The number of employees fell by 2, from 203 to 201, whereas debts increased from 224 million lei to 526 million lei. The company"s receivables also increased, from 211 million lei to 462 million lei.
* "Terapia", a profit two times greater than in 2009
In 2010, "Terapia" saw a net profit of 74.86 million lei, two times greater than the one of 2009, of 38.8 million lei. During the reviewed period, turnover also increased, from about 261 million to 377 million lei. The number of employees and the level of debts have decreased, from 782 to 677 employees, and from 84.9 million lei to 68 million lei, respectively. Receivables also increased, from 193 million lei to 249 million lei.
* "Zentiva" went from losses of 2.9 million lei in 2009 to a profit of 57 million lei last year
"Zentiva" had a spectacular evolution in 2010, going from a loss of 2.9 million lei in 2009 to a
